Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma

A compound having formula (I), wherein A is selected from the group consisting of: (i) phenyl, wherein said phenyl is optionally substituted by one or more halogen atoms, C1-6alkyl, C1-3alkoxy, C1-3fluoroalkoxy, nitrile, or -NR7R8 where R7 and R8 are independently hydrogen or C1-3alkyl; (ii) a 5- or...

Full description

Saved in:
Bibliographic Details
Main Authors BOSWELL GRADY EVAN, KALDOR ISTVAN, WILLSON TIMOTHY MARK, DEATON DAVID NORMAN, BRACKEEN MARCUS, SHARP MATTHEW JUDE, ERICKSON GREG ALAN, MOOK, ROBERT ANTHONY, JR, COLLINS JON LOREN, O'CALLAGHAN JOHN MARK, COBB JEFFREY EDMOND
Format Patent
LanguageEnglish
Published 14.11.2003
Edition7
Subjects
Online AccessGet full text

Cover

Loading…
Abstract A compound having formula (I), wherein A is selected from the group consisting of: (i) phenyl, wherein said phenyl is optionally substituted by one or more halogen atoms, C1-6alkyl, C1-3alkoxy, C1-3fluoroalkoxy, nitrile, or -NR7R8 where R7 and R8 are independently hydrogen or C1-3alkyl; (ii) a 5- or 6-membered hetrocyclic group containing at least one heteroatom selected from oxygen, nitrogen and sulfur; and (iii) a fused bicyclic ring (a), wherein ring C represents a heterocyclic group as defined in point (ii) above, which bicyclic ring is attached to group B via a ring atom of ring C; B is selected from the group consisting of: (iv) C1-6alkylene; (v) -MC1-6alkylene or C1-6alkyleneMC1-6alkylene, wherein M is O, S, or -NR2 wherein R2 represents hydrogen or C1-3alkyl; (vi) a 5- or 6-membered heterocyclic group containing at least one nitrogen heteroatom and optionally at least one further heteroatom selected from oxygen, nitrogen and sulfur and optionally substituted by C1-3alkyl; and (vii) Het-C1-6alkylene, wherein Het represents a heterocyclic group as defined in point (vi) above; Alk represents C1-3alkylene; R1 represents hydrogen or C1-3alkyl; Z is selected from the group consisting of: (viii) -(C1-3alkylene) phenyl, which phenyl is optionally substituted by one or more halogen atoms; and (ix) -NR3R4, wherein R3 represents hydrogen or C1-3alkyl, and R4 represents -Y-(C=O)-T-R5, or -Y-(CH(OH))-T-R5.
AbstractList A compound having formula (I), wherein A is selected from the group consisting of: (i) phenyl, wherein said phenyl is optionally substituted by one or more halogen atoms, C1-6alkyl, C1-3alkoxy, C1-3fluoroalkoxy, nitrile, or -NR7R8 where R7 and R8 are independently hydrogen or C1-3alkyl; (ii) a 5- or 6-membered hetrocyclic group containing at least one heteroatom selected from oxygen, nitrogen and sulfur; and (iii) a fused bicyclic ring (a), wherein ring C represents a heterocyclic group as defined in point (ii) above, which bicyclic ring is attached to group B via a ring atom of ring C; B is selected from the group consisting of: (iv) C1-6alkylene; (v) -MC1-6alkylene or C1-6alkyleneMC1-6alkylene, wherein M is O, S, or -NR2 wherein R2 represents hydrogen or C1-3alkyl; (vi) a 5- or 6-membered heterocyclic group containing at least one nitrogen heteroatom and optionally at least one further heteroatom selected from oxygen, nitrogen and sulfur and optionally substituted by C1-3alkyl; and (vii) Het-C1-6alkylene, wherein Het represents a heterocyclic group as defined in point (vi) above; Alk represents C1-3alkylene; R1 represents hydrogen or C1-3alkyl; Z is selected from the group consisting of: (viii) -(C1-3alkylene) phenyl, which phenyl is optionally substituted by one or more halogen atoms; and (ix) -NR3R4, wherein R3 represents hydrogen or C1-3alkyl, and R4 represents -Y-(C=O)-T-R5, or -Y-(CH(OH))-T-R5.
Author BRACKEEN MARCUS
O'CALLAGHAN JOHN MARK
COBB JEFFREY EDMOND
SHARP MATTHEW JUDE
WILLSON TIMOTHY MARK
BOSWELL GRADY EVAN
DEATON DAVID NORMAN
MOOK, ROBERT ANTHONY, JR
COLLINS JON LOREN
KALDOR ISTVAN
ERICKSON GREG ALAN
Author_xml – fullname: BOSWELL GRADY EVAN
– fullname: KALDOR ISTVAN
– fullname: WILLSON TIMOTHY MARK
– fullname: DEATON DAVID NORMAN
– fullname: BRACKEEN MARCUS
– fullname: SHARP MATTHEW JUDE
– fullname: ERICKSON GREG ALAN
– fullname: MOOK, ROBERT ANTHONY, JR
– fullname: COLLINS JON LOREN
– fullname: O'CALLAGHAN JOHN MARK
– fullname: COBB JEFFREY EDMOND
BookMark eNqFyT0OwjAMQOEMMPB3BCRfIEMpCysViB2WTpVJTGOpTaLGLeT2dGBnetL71mrhg6eVqu_jMwnLKGThqF22Q_hkHR353GFn0Ac2gIYtWBp4QuGJErxZHGAbPCeZdZ4sGSRAjDjoFvset2r5wi7R7teN2l8vj-qmKYaGUkRDnqSp6kNZnM5F-c-_uXY7mA
ContentType Patent
DBID EVB
DatabaseName esp@cenet
DatabaseTitleList
Database_xml – sequence: 1
  dbid: EVB
  name: esp@cenet
  url: http://worldwide.espacenet.com/singleLineSearch?locale=en_EP
  sourceTypes: Open Access Repository
DeliveryMethod fulltext_linktorsrc
Discipline Medicine
Chemistry
Sciences
Edition 7
ExternalDocumentID CY2319B1
GroupedDBID EVB
ID FETCH-epo_espacenet_CY2319B13
IEDL.DBID EVB
IngestDate Fri Jul 19 12:56:25 EDT 2024
IsOpenAccess true
IsPeerReviewed false
IsScholarly false
Language English
LinkModel DirectLink
MergedId FETCHMERGED-epo_espacenet_CY2319B13
Notes Application Number: CY20030000026
OpenAccessLink https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20031114&DB=EPODOC&CC=CY&NR=2319B1
ParticipantIDs epo_espacenet_CY2319B1
PublicationCentury 2000
PublicationDate 20031114
PublicationDateYYYYMMDD 2003-11-14
PublicationDate_xml – month: 11
  year: 2003
  text: 20031114
  day: 14
PublicationDecade 2000
PublicationYear 2003
RelatedCompanies GLAXO GROUP LIMITED
RelatedCompanies_xml – name: GLAXO GROUP LIMITED
Score 2.5835981
Snippet A compound having formula (I), wherein A is selected from the group consisting of: (i) phenyl, wherein said phenyl is optionally substituted by one or more...
SourceID epo
SourceType Open Access Repository
SubjectTerms ACYCLIC OR CARBOCYCLIC COMPOUNDS
CHEMISTRY
HETEROCYCLIC COMPOUNDS
HUMAN NECESSITIES
HYGIENE
MEDICAL OR VETERINARY SCIENCE
METALLURGY
ORGANIC CHEMISTRY
PREPARATIONS FOR MEDICAL, DENTAL, OR TOILET PURPOSES
SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS ORMEDICINAL PREPARATIONS
Title Substituted 4-hydroxy-phenylalcanoic acid derivatives with agonist activity to ppar-gamma
URI https://worldwide.espacenet.com/publicationDetails/biblio?FT=D&date=20031114&DB=EPODOC&locale=&CC=CY&NR=2319B1
hasFullText 1
inHoldings 1
isFullTextHit
isPrint
link http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV1dS8MwFL3IFPVNp8OvSR6kb8FtbVd9KMLSjSHsA5myPY2kybbC1patKvv33qSd-qBvJYXQXHKak-TccwHu6rWZqs1sj85EI6ROo-FR4dqSekIKLpFyKFN5rtdvdl-d57E7LtQWOhfG-IR-GnNERFSIeM_M_zr9OcQKjLZycy8ibEqeOiM_sHa7Yxuh61hBy28PB8GAWYz5bGL1X3ykMY8t3CXtI4X2NBLaby2dkZL-Xk46J3AwxJ7i7BT2VFyGI7arulaGw15x2Y2PBe42ZzDR-M4v9SVx6GIrtfqEan3WdsmXGJ4kCgkPI0kkTqkP4-a9IfqQlfB5ot1xic5g0IUiSJaQNOVrOuerFT-Haqc9Yl2K3zj9DsaUTfKh2BUoxUmsLoDoXFdkElwo2XRcmz9ogx3lCpuHTYEM7hIqf_dx9d-LazjORWt1WnduoJSt31UVF99M3JrIfQHzh4zn
link.rule.ids 230,309,783,888,25576,76876
linkProvider European Patent Office
linkToHtml http://utb.summon.serialssolutions.com/2.0.0/link/0/eLvHCXMwdV3PT8IwFH4xaMSbokRUtAezWyOwjelhMaGDoPIrBg2cSLsWJIFtganhv_e1gHrQ29IlzfrSb_3afu97ANfl0liVxrZHx6ISUqdS8ahwbUk9IQWXSDmUqTzX7lSbL87jwB1s1BY6F8b4hH4ac0REVIh4T83_Ovk5xAqMtnJ5I6bYFN83-n5gbXfHNkLXsYKaX-91gy6zGPPZ0Oo8-0hj7mq4S9pFeu1pJNRfazojJfm9nDQOYa-HPUXpEeyoKAdZtq26loP99uayGx83uFsew1Dje32pL4lD31ZSq0-o1metZnyG4YmnIeHhVBKJU-rDuHkviT5kJXwSa3dcojMYdKEIksYkSfiCTvh8zk-g2Kj3WZPiN46-gzFiw_VQ7DxkojhSp0B0risyCS6UrDquzW-1wY5yhc3DqkAGV4D8332c_ffiCrLNfrs1aj10ns7hYC1gK9OycwGZdPGuirgQp-LSRPELu4yP2g
openUrl ctx_ver=Z39.88-2004&ctx_enc=info%3Aofi%2Fenc%3AUTF-8&rfr_id=info%3Asid%2Fsummon.serialssolutions.com&rft_val_fmt=info%3Aofi%2Ffmt%3Akev%3Amtx%3Apatent&rft.title=Substituted+4-hydroxy-phenylalcanoic+acid+derivatives+with+agonist+activity+to+ppar-gamma&rft.inventor=BOSWELL+GRADY+EVAN&rft.inventor=KALDOR+ISTVAN&rft.inventor=WILLSON+TIMOTHY+MARK&rft.inventor=DEATON+DAVID+NORMAN&rft.inventor=BRACKEEN+MARCUS&rft.inventor=SHARP+MATTHEW+JUDE&rft.inventor=ERICKSON+GREG+ALAN&rft.inventor=MOOK%2C+ROBERT+ANTHONY%2C+JR&rft.inventor=COLLINS+JON+LOREN&rft.inventor=O%27CALLAGHAN+JOHN+MARK&rft.inventor=COBB+JEFFREY+EDMOND&rft.date=2003-11-14&rft.externalDBID=B1&rft.externalDocID=CY2319B1